CONTERA PHARMA
Contera Pharma identifies and develops innovative treatments for patients suffering from movement disorders. They use their expertise in drug discovery and development in close collaboration with expert individuals and organizations to provide foundations for success. The lead project JM-010 is approved for Phase IIa clinical trials for treatment of dyskinesia associated with Parkinson's disease.
CONTERA PHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.conterapharma.com
Status:
Active
Contact:
45 59 27 88 47
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
Antoxis
Antoxis is developing treatments for various neurological conditions.
Methuselah Health
Methuselah Health identifies novel targets for treatment of ageing-related diseases.
Oryx GmbH & Co. KG
ORYX identifies and develops highly innovative translational immunotherapy projects in cancer indications.
Current Employees Featured
Founder
Official Site Inspections
http://www.conterapharma.com Semrush global rank: 6.33 M Semrush visits lastest month: 1.13 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Contera Pharma"
Home - Contera Pharma A/S
About Contera Pharma. Contera Pharma is a Danish biotech company with an affiliate in Seoul, South-Korea. We develop innovative therapies to improve life for people suffering from neurological disorders.See details»
Management - Contera Pharma A/S
Thomas Sager has a Ph.D. in neuroscience and more that 24 years of drug discovery experience acquired in the biotech and pharma industry. For more than a decade he has held various …See details»
Contera Pharma Welcomes New Board Members to Drive …
5 days ago [Hørsholm, Denmark – December 03, 2024] – Contera Pharma A/S, a clinical-stage biotech company pioneering treatments for neurological disorders, is proud to announce the …See details»
Contera Pharma Management Team | Org Chart - RocketReach
Conterapharma.com; 1 453083XXXX; View Similar People. Related Companies NORMA A/S. 28 $2.8m CytoVac AB. 10 $7m Apodan A/S. 19 $5.9m Unseen Bio. 11 $1m Biosyntia. 25 $7m …See details»
Contera Pharma - Crunchbase Company Profile
Organization. Contera Pharma . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 45 59 27 88 47; Contera Pharma …See details»
Contera Pharma CEO and Key Executive Team | Craft.co
Contera Pharma's Chief Executive Officer is Thomas Sager. Other executives include David MinChang Kwon, Managing Director; Kenneth V. Christensen, Chief Scientific Officer and 2 …See details»
Contera Pharma - Overview, News & Similar companies - ZoomInfo
Jul 29, 2020 Contera Pharma (www.conterapharma.com) is a Danish clinical stage biotech company focusing on discovery and development of new innovative drugs for treatment of …See details»
Contera Pharma Information - RocketReach
Conterapharma.com; Kenneth Christensen Chief Scientific Officer - Head of R and D at Contera Pharma Paris, Ile-De-France, France View. 1 gmail.com; 1 453083XXXX; Thomas Sager …See details»
Contera Pharma A/S - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Contera Pharma A/S of Hørsholm, Hovedstaden. Get the latest business insights from Dun & Bradstreet.See details»
Contera Pharma announces management changes to secure …
[Hørsholm, September 6, 2024] – Contera Pharma A/S, a clinical-stage biotech company developing innovative therapies to treat neurological disorders, is pleased to announce key …See details»
Contera Pharma A/S | DANISH BIO – DANSK BIOTEK
Contera Pharma identifies and develops innovative treatments for patients suffering from neurological disorders. Contera Pharma’s science is based on a precision medicine approach …See details»
Contera Pharma - Craft
Contera Pharma is a company that identifies and develops treatments for patients suffering from movement disorders. The company's lead project JM-010 is in phase II clinical trials for the …See details»
Contera Pharma - Products, Competitors, Financials, Employees ...
About Contera Pharma. Contera Pharma is a biotech company focused on developing innovative therapies for neurological disorders. The company's main offerings include a proprietary …See details»
Contera Pharma - Company Profile - Tracxn
Nov 18, 2024 Contera Pharma - Developer of new innovative drugs for the treatment of movement disorders. Acquired by Bukwang. Raised a total funding of $2.54M over 3 rounds …See details»
Team - Contera Pharma A/S
Bukwang. Bukwang Pharmaceutical Co., Ltd. was established on October 17th, 1960 and has since continued to produce excellent medications with the aim of improving global health for …See details»
Contera Pharma Email Format | conterapharma.com Emails
The most common Contera Pharma email format is [first] (ex. [email protected]), which is being used by 75.0% of Contera Pharma work email addresses. Other common Contera …See details»
Contera Pharma | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Company focus - Contera Pharma A/S
Bukwang. Bukwang Pharmaceutical Co., Ltd. was established on October 17th, 1960 and has since continued to produce excellent medications with the aim of improving global health for …See details»
CP-012 - Drug Targets, Indications, Patents - Synapse
Nov 30, 2024 Inactive Organization-Drug Highest Phase Phase 1. First Approval Date-Regulation-Login to view timeline. Related. 100 Clinical Results associated with CP-012. ... · …See details»
Business Development - Contera Pharma A/S
Please contact us at [email protected] if you wish to discuss collaboration, partnering, or licensing opportunities. Recent News. November 28, 2024 . Contera Pharma announces first …See details»